Innovation Institute Celebrates Accomplishments of Pitt Innovators
If ever there was a time to celebrate the power of innovation, it is in the wake of the wave of innovation unleashed by the SARS CoV-2 pandemic. At the …
Posted on by Mike Yeomans
If ever there was a time to celebrate the power of innovation, it is in the wake of the wave of innovation unleashed by the SARS CoV-2 pandemic. At the …
Posted on by Mike Yeomans
Two innovation teams from the School of Rehabilitation Sciences (SHRS) were awarded $10,000 each to advance their projects towards the market and the clinic in the second annual SHRS Innovation …
Posted on by Mike Yeomans
Since forming a startup around his oncolytic virus cancer therapy research six years ago, Steve Thorne has managed to attract two major pharmaceutical partners to develop portions of his platforms …
Posted on by OIE
Late in 2020, the Innovation Institute was honored to host the Director of the United States Patent and Trademark Office, Andrei Iancu, for a fireside chat with our Director, Evan …
Posted on by Mike Yeomans
Pancreatic cancer. Just hearing those words produces a chilling feeling of dread. It is among the most deadly and difficult to treat cancers, in part because it forms dense tumors …
Posted on by Mike Yeomans
The Henry L. Hillman Foundation has committed $25 million to the University of Pittsburgh to support research into vision restoration and care, in addition to supporting the region’s burgeoning life …
Posted on by Mike Yeomans
In honor of Black History Month, the Innovation Institute is highlighting the life of William Hunter Dammond, a civil engineer and inventor of a train signaling system that bore his …
Posted on by Mike Yeomans
University of Pittsburgh Faculty Elected Senior Members of the National Academy of Inventors The National Academy of Inventors (NAI) has selected three University of Pittsburgh professors among 61 academic inventors …
Posted on by Mike Yeomans
Two recent federal grants have supercharged the progress of a non-invasive nerve blocking or stimulating technology from the lab of Pitt associate professor of urology Changfeng Tai as the startup …
Posted on by Mike Yeomans
Stephen Popielarski, PhD, had been a mentor for Phase I Ventures, a Philadelphia-based startup accelerator that matches university startups with experienced entrepreneurs when he was asked to review a batch …
Posted on by Mike Yeomans
BlueSphere licensed technology from the lab of Mark Shlomchik, chair of the Department of Immunology at the Pitt Medical School, aimed at developing personalized T-cell therapies for cancer and other …
Posted on by Mike Yeomans
Forge Biologics, a Columbus, Ohio-based gene therapy manufacturing and development company, is set to begin Phase I and 2 clinical trials of a gene therapy to treat Krabbe Disease, a …